Галерея 3136102

Галерея 3136102

· Fahrradgeschäft · 1805 E Ruben M Torres Blvd Suite 13
· Schließt demnächst ⋅ 18:00 ⋅ Öffnet Fr um 13:00 · +1 956-545-0866
Ergebnisse beim Bewegen der Karte aktualisieren

Dashboard
Publications
Account settings
Log out

Journal List

Mediators Inflamm

v.2011; 2011

PMC3136102

Create a new collection

Add to an existing collection

Unable to load your collection due to an error
Please try again

Mediators Inflamm. 2011; 2011: 827565.
Published online 2011 May 25. doi: 10.1155/2011/827565
Find articles by Matthaios Speletas
Find articles by Nikoletta Argentou
Find articles by Konstantinos Ritis
1 Department of Immunology and Histocompatibility, Medical School, University of Thessaly, Biopolis 41110 Larissa, Greece
2 First Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece
3 Gastroenterology and Hepatology Division, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece
4 Department of Pathology, Hippokration Hospital, 54635 Thessaloniki, Greece
5 First Department of Internal Medicine, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece
*Matthaios Speletas: rg.htu.dem@lepsam
Received 2010 Dec 14; Accepted 2011 Feb 21.
Copyright © 2011 Matthaios Speletas et al.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nature Immunology . 2007; 8 (5):457–462. [ PubMed ] [ Google Scholar ]
2. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nature Immunology . 2001; 2 (9):816–822. [ PubMed ] [ Google Scholar ]
3. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunology . 2007; 8 (2):191–197. [ PubMed ] [ Google Scholar ]
4. Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4 + CD25 + regulatory T cells ex vivo. Blood . 2003; 102 (6):2180–2186. [ PubMed ] [ Google Scholar ]
5. Aandahl EM, Michaëlsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4 + CD25 + Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens. Journal of Virology . 2004; 78 (5):2454–2459. [ PMC free article ] [ PubMed ] [ Google Scholar ]
6. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology . 2003; 38 (6):1437–1448. [ PubMed ] [ Google Scholar ]
7. Cabrera R, Tu Z, Xu Y, et al. An immunomodulatory role for CD4 + CD25 + regulatory T lymphocytes in hepatitis C virus infection. Hepatology . 2004; 40 (5):1062–1071. [ PubMed ] [ Google Scholar ]
8. Stoop JN, Van Der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology . 2005; 41 (4):771–778. [ PubMed ] [ Google Scholar ]
9. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. Journal of Immunology . 2006; 177 (1):739–747. [ PubMed ] [ Google Scholar ]
10. Ward SM, Fox BC, Brown PJ, et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. Journal of Hepatology . 2007; 47 (3):316–324. [ PubMed ] [ Google Scholar ]
11. Franzese O, Kennedy PTF, Gehring AJ, et al. Modulation of the CD8 + -T-cell response by CD4 + CD25 + regulatory T cells in patients with hepatitis B virus infection. Journal of Virology . 2005; 79 (6):3322–3328. [ PMC free article ] [ PubMed ] [ Google Scholar ]
12. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infectious Diseases . 2007; 7 (12):804–813. [ PubMed ] [ Google Scholar ]
13. Kerr JFR, Cooksley WGE, Searle J, et al. The nature of piecemeal necrosis in chronic active hepatitis. Lancet . 1979; 2 (8147):827–828. [ PubMed ] [ Google Scholar ]
14. Rust C, Gores GJ. Apoptosis and liver disease. American Journal of Medicine . 2000; 108 (7):567–574. [ PubMed ] [ Google Scholar ]
15. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. Journal of Immunology . 2003; 171 (12):6323–6327. [ PubMed ] [ Google Scholar ]
16. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. Journal of Hepatology . 1995; 22 (6):696–699. [ PubMed ] [ Google Scholar ]
17. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. American Journal of Gastroenterology . 1999; 94 (9):2467–2474. [ PubMed ] [ Google Scholar ]
18. Ludwig J, Dickson ER, McDonald GSA. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Archiv . 1978; 379 (2):103–112. [ PubMed ] [ Google Scholar ]
19. Scheuer P. Primary biliary cirrhosis. Proceedings of the Royal Society of Medicine . 1967; 60 (12):1257–1260. [ PMC free article ] [ PubMed ] [ Google Scholar ]
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2T method. Methods . 2001; 25 (4):402–408. [ PubMed ] [ Google Scholar ]
21. Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. Journal of Virology . 1997; 71 (3):1739–1746. [ PMC free article ] [ PubMed ] [ Google Scholar ]
22. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. Journal of Experimental Medicine . 1995; 182 (5):1223–1230. [ PMC free article ] [ PubMed ] [ Google Scholar ]
23. Mochizuki K, Hayashi N, Hiramatsu N, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. Journal of Hepatology . 1996; 24 (1):1–7. [ PubMed ] [ Google Scholar ]
24. Luo KX, Zhu YF, Zhang LX, He HT, Wang XS, Zhang L. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. Journal of Viral Hepatitis . 1997; 4 (5):303–307. [ PubMed ] [ Google Scholar ]
25. Rodrigues CMP, Brites D, Serejo F, Costa A, Ramalho F, Carneiro De Moura M. Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis c patients. Journal of Viral Hepatitis . 2000; 7 (3):175–183. [ PubMed ] [ Google Scholar ]
26. Tagashira M, Yamamoto K, Fujio K, et al. Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis. Journal of Clinical Immunology . 2000; 20 (5):347–353. [ PubMed ] [ Google Scholar ]
27. Lee JY, Chae DW, Kim SM, et al. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection. Journal of Viral Hepatitis . 2004; 11 (2):130–135. [ PubMed ] [ Google Scholar ]
28. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. Journal of Clinical Investigation . 1995; 95 (5):2111–2119. [ PMC free article ] [ PubMed ] [ Google Scholar ]
29. Copaci I, Micu L, Voiculescu M. The role of cytokines in non-alcoholic steatohepatitis. A systematic review. Journal of Gastrointestinal and Liver Diseases . 2006; 15 (4):363–373. [ PubMed ] [ Google Scholar ]
30. Chen Q, Galleano M, Cederbaum AI. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. Journal of Biological Chemistry . 1997; 272 (23):14532–14541. [ PubMed ] [ Google Scholar ]
31. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine . 2002; 8 (11):1288–1295. [ PubMed ] [ Google Scholar ]
32. Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology . 2003; 125 (2):437–443. [ PubMed ] [ Google Scholar ]
33. Li Z, Oben JA, Yang S, et al. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology . 2004; 40 (2):434–441. [ PubMed ] [ Google Scholar ]
34. Chou AH, Tsai HF, Wu YY, et al. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing bid cleavage and activation of mitochondria apoptosis signaling pathway. Journal of Immunology . 2005; 174 (4):2160–2166. [ PubMed ] [ Google Scholar ]
35. Mundt B, Wirth T, Lender L, et al. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut . 2005; 54 (11):1590–1596. [ PMC free article ] [ PubMed ] [ Google Scholar ]
36. Malhi H, Barreyro FJ, Isomoto H, Bronk SF, Gores GJ. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut . 2007; 56 (8):1124–1131. [ PMC free article ] [ PubMed ] [ Google Scholar ]
37. Volkmann X, Fischer U, Bahr MJ, et al. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology . 2007; 46 (5):1498–1508. [ PubMed ] [ Google Scholar ]
38. Bortolami M, Kotsafti A, Cardin R, Farinati F. Fas/FasL system, IL-1 β expression and apoptosis in chronic HBV and HCV liver disease. Journal of Viral Hepatitis . 2008; 15 (7):515–522. [ PubMed ] [ Google Scholar ]
39. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1 β induces acute lung injury and chronic repair leading to pulmonary fibrosis. Journal of Clinical Investigation . 2001; 107 (12):1529–1536. [ PMC free article ] [ PubMed ] [ Google Scholar ]
40. McCall CE, Yoza BK. Gene silencing in severe systemic inflammation. American Journal of Respiratory and Critical Care Medicine . 2007; 175 (8):763–767. [ PMC free article ] [ PubMed ] [ Google Scholar ]
41. Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Current Opinion in Immunology . 2004; 16 (6):780–786. [ PubMed ] [ Google Scholar ]
42. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, De Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of I κ B α , an inhibitor of the transcription factor NF- κ B. Journal of Experimental Medicine . 1996; 183 (3):1013–1022. [ PMC free article ] [ PubMed ] [ Google Scholar ]
43. Carroll MB, Bond MI. Use of tumor necrosis factor- α inhibitors in patients with chronic hepatitis B infection. Seminars in Arthritis and Rheumatism . 2008; 38 (3):208–217. [ PubMed ] [ Google Scholar ]
44. Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA, Tacchini-Cottier F. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4 + CD25 + T cells. Journal of Immunology . 2002; 169 (6):3232–3241. [ PubMed ] [ Google Scholar ]
45. Hori S, Carvalho TL, Demengeot J. CD25 + CD4 + regulatory T cells suppress CD4 + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. European Journal of Immunology . 2002; 32 (5):1282–1291. [ PubMed ] [ Google Scholar ]
46. Wei HX, Chuang YAH, Li B, et al. CD4 + CD25 + Foxp3 + regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF- β -dependent manner in mice. Journal of Immunology . 2008; 181 (10):7221–7229. [ PubMed ] [ Google Scholar ]
47. Sakaki M, Hiroishi K, Baba T, et al. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatology Research . 2008; 38 (4):354–361. [ PubMed ] [ Google Scholar ]
48. Saeki C, Nakano M, Takahashi H, et al. Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation. Clinical Immunology . 2010; 135 (1):156–166. [ PubMed ] [ Google Scholar ]
49. Walport MJ. Complement. Second of two parts. New England Journal of Medicine . 2001; 344 (15):1140–1144. [ PubMed ] [ Google Scholar ]
50. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles in the Fas ligand in the development of hepatitis. Nature Medicine . 1997; 3 (4):409–413. [ PubMed ] [ Google Scholar ]
Articles from Mediators of Inflammation are provided here courtesy of Hindawi Limited
1. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nature Immunology . 2007; 8 (5):457–462. [ PubMed ] [ Google Scholar ] [ Ref list ]
2. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nature Immunology . 2001; 2 (9):816–822. [ PubMed ] [ Google Scholar ] [ Ref list ]
3. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunology . 2007; 8 (2):191–197. [ PubMed ] [ Google Scholar ] [ Ref list ]
4. Jiang S, Camara N, Lombardi G, Lechler RI. Induction of allopeptide-specific human CD4 + CD25 + regulatory T cells ex vivo. Blood . 2003; 102 (6):2180–2186. [ PubMed ] [ Google Scholar ] [ Ref list ]
5. Aandahl EM, Michaëlsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4 + CD25 + Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens. Journal of Virology . 2004; 78 (5):2454–2459. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
6. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology . 2003; 38 (6):1437–1448. [ PubMed ] [ Google Scholar ] [ Ref list ]
8. Stoop JN, Van Der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology . 2005; 41 (4):771–778. [ PubMed ] [ Google Scholar ] [ Ref list ]
9. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. Journal of Immunology . 2006; 177 (1):739–747. [ PubMed ] [ Google Scholar ] [ Ref list ]
11. Franzese O, Kennedy PTF, Gehring AJ, et al. Modulation of the CD8 + -T-cell response by CD4 + CD25 + regulatory T cells in patients with hepatitis B virus infection. Journal of Virology . 2005; 79 (6):3322–3328. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
10. Ward SM, Fox BC, Brown PJ, et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. Journal of Hepatology . 2007; 47 (3):316–324. [ PubMed ] [ Google Scholar ] [ Ref list ]
12. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infectious Diseases . 2007; 7 (12):804–813. [ PubMed ] [ Google Scholar ] [ Ref list ]
13. Kerr JFR, Cooksley WGE, Searle J, et al. The nature of piecemeal necrosis in chronic active hepatitis. Lancet . 1979; 2 (8147):827–828. [ PubMed ] [ Google Scholar ] [ Ref list ]
14. Rust C, Gores GJ. Apoptosis and liver disease. American Journal of Medicine . 2000; 108 (7):567–574. [ PubMed ] [ Google Scholar ] [ Ref list ]
15. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. Journal of Immunology . 2003; 171 (12):6323–6327. [ PubMed ] [ Google Scholar ] [ Ref list ]
16. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. Journal of Hepatology . 1995; 22 (6):696–699. [ PubMed ] [ Google Scholar ] [ Ref list ]
17. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. American Journal of Gastroenterology . 1999; 94 (9):2467–2474. [ PubMed ] [ Google Scholar ] [ Ref list ]
18. Ludwig J, Dickson ER, McDonald GSA. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Archiv . 1978; 379 (2):103–112. [ PubMed ] [ Google Scholar ] [ Ref list ]
19. Scheuer P. Primary biliary cirrhosis. Proceedings of the Royal Society of Medicine . 1967; 60 (12):1257–1260. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2T method. Methods . 2001; 25 (4):402–408. [ PubMed ] [ Google Scholar ] [ Ref list ]
21. Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. Journal of Virology . 1997; 71 (3):1739–1746. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
22. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. Journal of Experimental Medicine . 1995; 182 (5):1223–1230. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
27. Lee JY, Chae DW, Kim SM, et al. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection. Journal of Viral Hepatitis . 2004; 11 (2):130–135. [ PubMed ] [ Google Scholar ] [ Ref list ]
26. Tagashira M, Yamamoto K, Fujio K, et al. Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis. Journal of Clinical Immunology . 2000; 20 (5):347–353. [ PubMed ] [ Google Scholar ] [ Ref list ]
28. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. Journal of Clinical Investigation . 1995; 95 (5):2111–2119. [ PMC free article ] [ PubMed ] [ Google Scholar ] [ Ref list ]
29. Copaci I, Micu L, Voiculescu M. The role of cytokines in non-alcoholic steatohepatitis. A systematic review. Journal of Gastrointestinal and Liver Diseases . 2006; 15 (4):363–373. [ PubMed ] [ Google Scholar ] [ Ref list ]
30. Chen Q, Galleano M, Cederbaum AI. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. Journal of Biological Chemistry . 1997; 272 (23):14532–14541. [ PubMed ] [ Google Scholar ] [ Ref list ]
33. Li Z, Oben JA, Yang S, et al. Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology . 2004; 40 (2):434–441. [ PubMed ] [ Google Scholar ] [ Ref list ]
32. Feldstein AE, Can
В белых чулках и корсете
Ценная штучка
Первая порно съемка сексапильной Анечки

Галерея 3136102

Report Page